Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg ...

A new study finds that obesity and high blood pressure may directly cause dementia, not just increase the risk.

A growing body of research suggests that what’s missing from the body may matter just as much as what viruses are circulating ...

A growing body of research suggests that what’s missing from the body may matter just as much as what viruses are circulating ...

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...

By Dr. Sanchari Sinha Dutta, Ph.D. A year of consistent aerobic activity didn’t just boost fitness; it shifted MRI -based ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

For optometrists, 2026 provides ample opportunity to continue the charge in advancements in dry eye, artificial intelligence ...

People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism.

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

If used at the population level, it could contribute to antimicrobial resistance, so using clinical judgement is critical ...